Skip to content
All Podcasts – Lifestyle
Author:
NurExone Biologic Inc
NurExone Expands U.S. Engagement Across Four Major Boston Life Sciences Events and Provides Corporate Update
September 18, 2026
NurExone Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update
September 16, 2026
NurExone and NanoPass Technologies Ltd. to Collaborate on Integrated Exosome Delivery Approach for Regenerative Eye and Skin Applications
September 14, 2026
Fractal establishes India Business Unit to meet increasing demand from large Indian enterprises
August 29, 2026
NurExone Announces Annual General and Special Meeting to Consider Share Consolidation in Support of U.S. Capital Markets Strategy
August 21, 2026
NurExone Announces Closing of C$1,066,078 Private Placement
August 20, 2026
NurExone Reports New Preclinical Tissue-Analysis Data Supporting Potential Neuroprotective Effect of ExoPTEN in Acute Spinal Cord Injury Animal Model
August 14, 2026
NurExone Announces Binding MOU with Made Scientific for U.S. GMP Manufacturing and Commercial Supply Partnership
August 12, 2026
NurExone Launches Bioprocess Optimization Initiative to Support Commercial and Clinical Readiness
July 30, 2026
Corporate Updates – NurExone appoints Mr. David Stolick to the Board of Directors
July 28, 2026
1
2
Next Page
→